{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:54:34Z","timestamp":1790150074220,"version":"4.0.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","award":["10-002028"],"award-info":[{"award-number":["10-002028"]}],"id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004954","name":"Augustinus Fonden","doi-asserted-by":"publisher","award":["17-4115"],"award-info":[{"award-number":["17-4115"]}],"id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00018-019-03051-2","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T08:10:10Z","timestamp":1551687010000},"page":"2449-2461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Enhanced cerebral branched-chain amino acid metabolism in R6\/2 mouse model of Huntington\u2019s disease"],"prefix":"10.1007","volume":"76","author":[{"given":"Jens V.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels H.","family":"Skotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca I.","family":"Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"N\u00f8rrem\u00f8lle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4583-8379","authenticated-orcid":false,"given":"Helle S.","family":"Waagepetersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"3051_CR1","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP et al (2015) Huntington disease. Nat Rev Dis Primers 1:15005","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3051_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10(1):83\u201398","journal-title":"Lancet Neurol"},{"issue":"6","key":"3051_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72(6):971\u2013983","journal-title":"Cell"},{"issue":"3","key":"3051_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","volume":"29","author":"SE Browne","year":"2004","unstructured":"Browne SE, Beal MF (2004) The energetics of Huntington\u2019s disease. Neurochem Res 29(3):531\u2013546","journal-title":"Neurochem Res"},{"issue":"2","key":"3051_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI45691","volume":"121","author":"F Mochel","year":"2011","unstructured":"Mochel F, Haller RG (2011) Energy deficit in Huntington disease: why it matters. J Clin Invest 121(2):493\u2013499","journal-title":"J Clin Invest"},{"key":"3051_CR6","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1038\/ncomms3917","volume":"4","author":"AI Acuna","year":"2013","unstructured":"Acuna AI et al (2013) A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington\u2019s disease in mice. Nat Commun 4:2917","journal-title":"Nat Commun"},{"issue":"20","key":"3051_CR7","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J et al (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet 19(20):3919\u20133935","journal-title":"Hum Mol Genet"},{"issue":"2","key":"3051_CR8","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1074\/jbc.M111.309849","volume":"287","author":"F Mochel","year":"2012","unstructured":"Mochel F et al (2012) Early alterations of brain cellular energy homeostasis in Huntington disease models. J Biol Chem 287(2):1361\u20131370","journal-title":"J Biol Chem"},{"issue":"8","key":"3051_CR9","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1073\/pnas.0609833104","volume":"104","author":"WJ Powers","year":"2007","unstructured":"Powers WJ et al (2007) Selective defect of in vivo glycolysis in early Huntington\u2019s disease striatum. Proc Natl Acad Sci U S A 104(8):2945\u20132949","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3051_CR10","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.15252\/embj.201695810","volume":"36","author":"S Camandola","year":"2017","unstructured":"Camandola S, Mattson MP (2017) Brain metabolism in health, aging, and neurodegeneration. EMBO J 36(11):1474\u20131492","journal-title":"EMBO J"},{"issue":"1","key":"3051_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W","volume":"21","author":"M Yudkoff","year":"1997","unstructured":"Yudkoff M (1997) Brain metabolism of branched-chain amino acids. Glia 21(1):92\u201398","journal-title":"Glia"},{"issue":"6","key":"3051_CR12","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s11064-017-2261-5","volume":"42","author":"JE Sperringer","year":"2017","unstructured":"Sperringer JE, Addington A, Hutson SM (2017) Branched-chain amino acids and brain metabolism. Neurochem Res 42(6):1697\u20131709","journal-title":"Neurochem Res"},{"key":"3051_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-319-45096-4_5","volume":"13","author":"ME Conway","year":"2016","unstructured":"Conway ME, Hutson SM (2016) BCAA metabolism and NH3 homeostasis. Adv Neurobiol 13:99\u2013132","journal-title":"Adv Neurobiol"},{"issue":"4","key":"3051_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17(4):448\u2013453","journal-title":"Nat Med"},{"issue":"8","key":"3051_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jalz.2016.01.008","volume":"12","author":"HH Ruiz","year":"2016","unstructured":"Ruiz HH et al (2016) Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer\u2019s disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels. Alzheimers Dement 12(8):851\u2013861","journal-title":"Alzheimers Dement"},{"issue":"6105","key":"3051_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1126\/science.1224631","volume":"338","author":"G Novarino","year":"2012","unstructured":"Novarino G et al (2012) Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science 338(6105):394\u2013397","journal-title":"Science"},{"issue":"6","key":"3051_CR17","doi-asserted-by":"publisher","first-page":"1481.e18","DOI":"10.1016\/j.cell.2016.11.013","volume":"167","author":"DC Tarlungeanu","year":"2016","unstructured":"Tarlungeanu DC et al (2016) Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder. Cell 167(6):1481.e18\u20131494.e18","journal-title":"Cell"},{"issue":"7599","key":"3051_CR18","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0140-6736(69)92068-6","volume":"1","author":"TL Perry","year":"1969","unstructured":"Perry TL et al (1969) Plasma-aminoacid levels in Huntington\u2019s chorea. Lancet 1(7599):806\u2013808","journal-title":"Lancet"},{"issue":"1","key":"3051_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1212\/WNL.22.1.68","volume":"22","author":"TL Perry","year":"1972","unstructured":"Perry TL, Hansen S, Lesk D (1972) Plasma amino acid levels in children of patients with Huntington\u2019s chorea. Neurology 22(1):68\u201370","journal-title":"Neurology"},{"issue":"7","key":"3051_CR20","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","volume":"2","author":"F Mochel","year":"2007","unstructured":"Mochel F et al (2007) Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One 2(7):e647","journal-title":"PLoS One"},{"issue":"2","key":"3051_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/archneurol.2010.358","volume":"68","author":"F Mochel","year":"2011","unstructured":"Mochel F et al (2011) Validation of plasma branched chain amino acids as biomarkers in Huntington disease. Arch Neurol 68(2):265\u2013267","journal-title":"Arch Neurol"},{"issue":"9","key":"3051_CR22","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.bbadis.2016.06.007","volume":"1862","author":"SF Graham","year":"2016","unstructured":"Graham SF et al (2016) Metabolic signatures of Huntington\u2019s disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain. Biochim Biophys Acta 1862(9):1675\u20131684","journal-title":"Biochim Biophys Acta"},{"key":"3051_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jnutbio.2015.12.001","volume":"31","author":"ML Cheng","year":"2016","unstructured":"Cheng ML et al (2016) Metabolic disturbances in plasma as biomarkers for Huntington\u2019s disease. J Nutr Biochem 31:38\u201344","journal-title":"J Nutr Biochem"},{"issue":"5","key":"3051_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1212\/WNL.0000000000001214","volume":"84","author":"IM Adanyeguh","year":"2015","unstructured":"Adanyeguh IM et al (2015) Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology 84(5):490\u2013495","journal-title":"Neurology"},{"issue":"11","key":"3051_CR25","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1002\/jnr.24111","volume":"95","author":"F Mochel","year":"2017","unstructured":"Mochel F (2017) Triheptanoin for the treatment of brain energy deficit: a 14-year experience. J Neurosci Res 95(11):2236\u20132243","journal-title":"J Neurosci Res"},{"issue":"4","key":"3051_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/jnc.12812","volume":"131","author":"U Sonnewald","year":"2014","unstructured":"Sonnewald U (2014) Glutamate synthesis has to be matched by its degradation\u2014where do all the carbons go? J Neurochem 131(4):399\u2013406","journal-title":"J Neurochem"},{"issue":"7","key":"3051_CR27","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","volume":"23","author":"NH Skotte","year":"2018","unstructured":"Skotte NH et al (2018) Integrative characterization of the R6\/2 mouse model of Huntington\u2019s disease reveals dysfunctional astrocyte metabolism. Cell Rep 23(7):2211\u20132224","journal-title":"Cell Rep"},{"issue":"3","key":"3051_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87(3):493\u2013506","journal-title":"Cell"},{"issue":"1","key":"3051_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/hmg\/3.1.65","volume":"3","author":"SE Andrew","year":"1994","unstructured":"Andrew SE et al (1994) A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing. Hum Mol Genet 3(1):65\u201367","journal-title":"Hum Mol Genet"},{"issue":"3","key":"3051_CR30","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1177\/0271678X16684154","volume":"37","author":"JV Andersen","year":"2017","unstructured":"Andersen JV et al (2017) Improved cerebral energetics and ketone body metabolism in db\/db mice. J Cereb Blood Flow Metab 37(3):1137\u20131147","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"3051_CR31","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s11064-016-2116-5","volume":"42","author":"LF McNair","year":"2017","unstructured":"McNair LF et al (2017) Metabolic characterization of acutely isolated hippocampal and cerebral cortical slices using [U-13C]glucose and [1,2-13C]acetate as substrates. Neurochem Res 42(3):810\u2013826","journal-title":"Neurochem Res"},{"issue":"1","key":"3051_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76\u201385","journal-title":"Anal Biochem"},{"key":"3051_CR33","doi-asserted-by":"crossref","unstructured":"Walls AB et al (2014) Metabolic mapping of astrocytes and neurons in culture using stable isotopes and gas chromatography-mass spectrometry (GC\u2013MS). In: Hirrlinger J, Waagepetersen HS (eds) Brain energy metabolism. Neuromethods, vol 90. Humana Press, New York","DOI":"10.1007\/978-1-4939-1059-5_4"},{"issue":"6","key":"3051_CR34","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s11064-016-2070-2","volume":"42","author":"JV Andersen","year":"2017","unstructured":"Andersen JV et al (2017) Alterations in cerebral cortical glucose and glutamine metabolism precedes amyloid plaques in the APPswe\/PSEN1dE9 mouse model of Alzheimer\u2019s disease. Neurochem Res 42(6):1589\u20131598","journal-title":"Neurochem Res"},{"key":"3051_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuint.2017.02.010","volume":"106","author":"BI Aldana","year":"2017","unstructured":"Aldana BI et al (2017) Characterization of energy and neurotransmitter metabolism in cortical glutamatergic neurons derived from human induced pluripotent stem cells: a novel approach to study metabolism in human neurons. Neurochem Int 106:48\u201361","journal-title":"Neurochem Int"},{"issue":"Pt 8","key":"3051_CR36","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/brain\/awf180","volume":"125","author":"PF Behrens","year":"2002","unstructured":"Behrens PF et al (2002) Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 125(Pt 8):1908\u20131922","journal-title":"Brain"},{"issue":"5","key":"3051_CR37","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/j.1471-4159.2006.04323.x","volume":"100","author":"I Tkac","year":"2007","unstructured":"Tkac I et al (2007) Neurochemical changes in Huntington R6\/2 mouse striatum detected by in vivo 1H NMR spectroscopy. J Neurochem 100(5):1397\u20131406","journal-title":"J Neurochem"},{"issue":"3","key":"3051_CR38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1021\/pr050244o","volume":"5","author":"TM Tsang","year":"2006","unstructured":"Tsang TM et al (2006) Metabolic characterization of the R6\/2 transgenic mouse model of Huntington\u2019s disease by high-resolution MAS 1H NMR spectroscopy. J Proteome Res 5(3):483\u2013492","journal-title":"J Proteome Res"},{"issue":"3","key":"3051_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/jcbfm.2011.157","volume":"32","author":"L Zacharoff","year":"2012","unstructured":"Zacharoff L et al (2012) Cortical metabolites as biomarkers in the R6\/2 model of Huntington\u2019s disease. J Cereb Blood Flow Metab 32(3):502\u2013514","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1\u20132","key":"3051_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbrc.2015.10.140","volume":"468","author":"S Patassini","year":"2015","unstructured":"Patassini S et al (2015) Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington\u2019s disease. Biochem Biophys Res Commun 468(1\u20132):161\u2013166","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3051_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0006-291X(83)90985-3","volume":"115","author":"M Yudkoff","year":"1983","unstructured":"Yudkoff M et al (1983) [15\u00a0N] leucine as a source of [15\u00a0N] glutamate in organotypic cerebellar explants. Biochem Biophys Res Commun 115(1):174\u2013179","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3051_CR42","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1046\/j.1471-4159.1998.70031304.x","volume":"70","author":"K Kanamori","year":"1998","unstructured":"Kanamori K, Ross BD, Kondrat RW (1998) Rate of glutamate synthesis from leucine in rat brain measured in vivo by 15\u00a0N NMR. J Neurochem 70(3):1304\u20131315","journal-title":"J Neurochem"},{"issue":"3","key":"3051_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/cdd.2016.139","volume":"24","author":"NH Skotte","year":"2017","unstructured":"Skotte NH et al (2017) Palmitoylation of caspase-6 by HIP14 regulates its activation. Cell Death Differ 24(3):433\u2013444","journal-title":"Cell Death Differ"},{"issue":"1","key":"3051_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","volume":"40","author":"K Huang","year":"2010","unstructured":"Huang K et al (2010) Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease. Neurobiol Dis 40(1):207\u2013215","journal-title":"Neurobiol Dis"},{"issue":"12","key":"3051_CR45","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","volume":"4","author":"M Perluigi","year":"2005","unstructured":"Perluigi M et al (2005) Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease. Mol Cell Proteomics 4(12):1849\u20131861","journal-title":"Mol Cell Proteomics"},{"issue":"16","key":"3051_CR46","doi-asserted-by":"publisher","first-page":"11893","DOI":"10.1074\/jbc.M700198200","volume":"282","author":"MM Islam","year":"2007","unstructured":"Islam MM et al (2007) A novel branched-chain amino acid metabolon. Protein-protein interactions in a supramolecular complex. J Biol Chem 282(16):11893\u201311903","journal-title":"J Biol Chem"},{"key":"3051_CR47","volume-title":"Branched chain amino acids in clinical nutrition","author":"JT Cole","year":"2015","unstructured":"Cole JT (2015) Metabolism of BCAAs. In: Rajendram R, Preedy VR, Patel VB (eds) Branched chain amino acids in clinical nutrition. Humana Press, New York"},{"issue":"1 Suppl","key":"3051_CR48","doi-asserted-by":"publisher","first-page":"207s","DOI":"10.1093\/jn\/136.1.207S","volume":"136","author":"JT Brosnan","year":"2006","unstructured":"Brosnan JT, Brosnan ME (2006) Branched-chain amino acids: enzyme and substrate regulation. J Nutr 136(1 Suppl):207s\u2013211s","journal-title":"J Nutr"},{"issue":"10","key":"3051_CR49","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","volume":"7","author":"JM Karasinska","year":"2011","unstructured":"Karasinska JM, Hayden MR (2011) Cholesterol metabolism in Huntington disease. Nat Rev Neurol 7(10):561\u2013572","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3051_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","volume":"28","author":"M Valenza","year":"2007","unstructured":"Valenza M et al (2007) Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 28(1):133\u2013142","journal-title":"Neurobiol Dis"},{"issue":"6","key":"3051_CR51","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/jnc.12044","volume":"123","author":"J Hull","year":"2012","unstructured":"Hull J et al (2012) Distribution of the branched chain aminotransferase proteins in the human brain and their role in glutamate regulation. J Neurochem 123(6):997\u20131009","journal-title":"J Neurochem"},{"issue":"3","key":"3051_CR52","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","volume":"98","author":"LK Bak","year":"2006","unstructured":"Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98(3):641\u2013653","journal-title":"J Neurochem"},{"issue":"2","key":"3051_CR53","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11064-014-1473-1","volume":"40","author":"AB Walls","year":"2015","unstructured":"Walls AB et al (2015) The glutamine-glutamate\/GABA cycle: function, regional differences in glutamate and GABA production and effects of interference with GABA metabolism. Neurochem Res 40(2):402\u2013409","journal-title":"Neurochem Res"},{"issue":"5","key":"3051_CR54","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nn.4532","volume":"20","author":"RG Lim","year":"2017","unstructured":"Lim RG, Salazar LL, Wilton DK, King AR, Stocksdale JT, Sharifabad D, Lau AL, Stevens B, Reidling JC, Winokur ST, Casale MS (2017) Developmental alterations in Huntington\u2019s disease neural cells and pharmacological rescue in cells and mice. Nat Neurosci 20(5):648\u2013660","journal-title":"Nat Neurosci"},{"issue":"7\u20138","key":"3051_CR55","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuint.2007.01.009","volume":"50","author":"ML Johansen","year":"2007","unstructured":"Johansen ML et al (2007) The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes. Neurochem Int 50(7\u20138):1042\u20131051","journal-title":"Neurochem Int"},{"key":"3051_CR56","first-page":"cd001939","volume":"5","author":"LL Gluud","year":"2017","unstructured":"Gluud LL et al (2017) Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev 5:cd001939","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3051_CR57","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11011-013-9381-7","volume":"28","author":"LK Bak","year":"2013","unstructured":"Bak LK et al (2013) Role of branched chain amino acids in cerebral ammonia homeostasis related to hepatic encephalopathy. Metab Brain Dis 28(2):209\u2013215","journal-title":"Metab Brain Dis"},{"key":"3051_CR58","doi-asserted-by":"publisher","first-page":"43030","DOI":"10.1038\/srep43030","volume":"7","author":"DJ Skene","year":"2017","unstructured":"Skene DJ et al (2017) Metabolic profiling of presymptomatic Huntington\u2019s disease sheep reveals novel biomarkers. Sci Rep 7:43030","journal-title":"Sci Rep"},{"issue":"5","key":"3051_CR59","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/hmg\/ddl481","volume":"16","author":"MC Chiang","year":"2007","unstructured":"Chiang MC et al (2007) Dysregulation of C\/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington\u2019s disease. Hum Mol Genet 16(5):483\u2013498","journal-title":"Hum Mol Genet"},{"issue":"1\u20132","key":"3051_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuint.2005.04.002","volume":"47","author":"P Ott","year":"2005","unstructured":"Ott P, Clemmesen O, Larsen FS (2005) Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochem Int 47(1\u20132):13\u201318","journal-title":"Neurochem Int"},{"key":"3051_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-319-08894-5_2","volume":"11","author":"A Schousboe","year":"2014","unstructured":"Schousboe A et al (2014) Glutamate metabolism in the brain focusing on astrocytes. Adv Neurobiol 11:13\u201330","journal-title":"Adv Neurobiol"},{"issue":"35","key":"3051_CR62","doi-asserted-by":"publisher","first-page":"11090","DOI":"10.1073\/pnas.1508259112","volume":"112","author":"R Lerchundi","year":"2015","unstructured":"Lerchundi R et al (2015) NH4(+) triggers the release of astrocytic lactate via mitochondrial pyruvate shunting. Proc Natl Acad Sci USA 112(35):11090\u201311095","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"3051_CR63","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s12640-010-9198-7","volume":"19","author":"R Leke","year":"2011","unstructured":"Leke R et al (2011) Detoxification of ammonia in mouse cortical GABAergic cell cultures increases neuronal oxidative metabolism and reveals an emerging role for release of glucose-derived alanine. Neurotox Res 19(3):496\u2013510","journal-title":"Neurotox Res"},{"issue":"3\u20134","key":"3051_CR64","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11011-007-9069-y","volume":"22","author":"C Zwingmann","year":"2007","unstructured":"Zwingmann C (2007) The anaplerotic flux and ammonia detoxification in hepatic encephalopathy. Metab Brain Dis 22(3\u20134):235\u2013249","journal-title":"Metab Brain Dis"},{"issue":"8","key":"3051_CR65","doi-asserted-by":"publisher","first-page":"e0161816","DOI":"10.1371\/journal.pone.0161816","volume":"11","author":"TW Tefera","year":"2016","unstructured":"Tefera TW et al (2016) Triheptanoin protects motor neurons and delays the onset of motor symptoms in a mouse model of amyotrophic lateral sclerosis. PLoS One 11(8):e0161816","journal-title":"PLoS One"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03051-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-019-03051-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03051-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:29:43Z","timestamp":1583177383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-019-03051-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["3051"],"URL":"https:\/\/doi.org\/10.1007\/s00018-019-03051-2","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"4 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}